Literature DB >> 17764538

ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock.

J A Kremer Hovinga1, S Zeerleder, P Kessler, T Romani de Wit, J A van Mourik, C E Hack, H ten Cate, P H Reitsma, W A Wuillemin, B Lämmle.   

Abstract

BACKGROUND: Insufficient control of von Willebrand factor (VWF) multimer size as a result of severely deficient ADAMTS-13 activity results in thrombotic thrombocytopenic purpura associated with microvascluar thrombosis and platelet consumption, features not seldom seen in severe sepsis and septic shock.
METHODS: ADAMTS-13 activity and VWF parameters of 40 patients with severe sepsis or septic shock were compared with those of 40 healthy controls of the same age and gender and correlated with clinical findings and sepsis outcome.
RESULTS: ADAMTS-13 activity was significantly lower in patients than in healthy controls [median 60% (range 27-160%) vs. 110% (range 63-200%); P < 0.001]. VWF parameters behaved reciprocally and both VWF ristocetin cofactor activity (RCo) and VWF antigen (VWF:Ag) were significantly (P < 0.001) higher in patients compared with controls. Neither ADAMTS-13 activity nor VWF parameters correlated with disease severity, organ dysfunction or outcome. However, a contribution of acute endothelial dysfunction to renal impairment in sepsis is suggested by the significantly higher VWF propeptide and soluble thrombomodulin levels in patients with increased creatinine values as well as by their strong positive correlations (creatinine and VWF propeptide r(s) = 0.484, P < 0.001; creatinine and soluble thrombomodulin r(s) = 0.596, P < 0.001).
CONCLUSIONS: VWF parameters are reciprocally correlated with ADAMTS-13 activity in severe sepsis and septic shock but have no prognostic value regarding outcome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17764538     DOI: 10.1111/j.1538-7836.2007.02743.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  54 in total

1.  von Willebrand factor is a cofactor in complement regulation.

Authors:  Shuju Feng; Xiaowen Liang; Michael H Kroll; Dominic W Chung; Vahid Afshar-Kharghan
Journal:  Blood       Date:  2014-11-13       Impact factor: 22.113

2.  Relevant role of von Willebrand factor in neutrophil recruitment in a mouse sepsis model involving cecal ligation and puncture.

Authors:  Shogo Kasuda; Hideto Matsui; Shiro Ono; Yasunori Matsunari; Kenji Nishio; Midori Shima; Katsuhiko Hatake; Mitsuhiko Sugimoto
Journal:  Haematologica       Date:  2015-10-22       Impact factor: 9.941

Review 3.  Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura.

Authors:  Minola Manea; Diana Karpman
Journal:  Pediatr Nephrol       Date:  2008-09-20       Impact factor: 3.714

4.  ADAMTS-13 regulates neutrophil recruitment in a mouse model of invasive pulmonary aspergillosis.

Authors:  Astrid Alflen; Steve Prüfer; Katharina Ebner; Sebastian Reuter; Pamela Aranda Lopez; Inge Scharrer; Fumiaki Banno; Michael Stassen; Hansjörg Schild; Kerstin Jurk; Markus Bosmann; Hendrik Beckert; Markus P Radsak
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

5.  Clinical Utility of Platelet Count as a Prognostic Marker for Melioidosis.

Authors:  Philippa Kirby; Simon Smith; Linda Ward; Josh Hanson; Bart J Currie
Journal:  Am J Trop Med Hyg       Date:  2019-05       Impact factor: 2.345

6.  ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice.

Authors:  Chintan Gandhi; Mohammad Moshahid Khan; Steven R Lentz; Anil K Chauhan
Journal:  Blood       Date:  2011-11-28       Impact factor: 22.113

Review 7.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

8.  Imbalances in serum angiopoietin concentrations are early predictors of septic shock development in patients with post chemotherapy febrile neutropenia.

Authors:  Brunna E Alves; Silmara A L Montalvao; Franciso J P Aranha; Tania F G Siegl; Carmino A Souza; Irene Lorand-Metze; Joyce M Annichino-Bizzacchi; Erich V De Paula
Journal:  BMC Infect Dis       Date:  2010-05-28       Impact factor: 3.090

9.  Von Willebrand factor, ADAMTS13 activity, TNF-α and their relationships in patients with chronic kidney disease.

Authors:  Lei Shen; Guoyuan Lu; Ningzheng Dong; Liqiong Jiang; Zhenni Ma; Changgeng Ruan
Journal:  Exp Ther Med       Date:  2011-12-23       Impact factor: 2.447

10.  Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait.

Authors:  Anwar Al-Awadhi; Adekunle Adekile; Rajaa Marouf
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.